ArticleCureus2026
Deep Learning-Based CT Segmentation of a Non-radiopaque Hydrogel Rectal Spacer in Prostate Radiotherapy.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe study evaluated the feasibility and geometric accuracy of CT-based automatic segmentation of a non-radiopaque hydrogel rectal spacer using a commercial deep learning platform (OncoStudio) and determined whether accurate spacer delineation can be achieved without MRI while preserving the contouring quality of adjacent organs.
methodsThis retrospective study included 21 patients with localized prostate cancer who underwent external beam radiotherapy with a non-radiopaque hydrogel rectal spacer (SpaceOAR; Boston Scientific). CT-based automatic segmentation of the rectal spacer, prostate, rectum, and bladder was performed on the planning CT using OncoStudio (version 2.0; Oncosoft Inc.). Reference contours were manually delineated on the planning CT with reference to co-registered T2-weighted MRI. Geometric accuracy was assessed using the Dice similarity coefficient (DSC), 95th-percentile Hausdorff distance (HD₉₅), and mean surface distance (MSD).
resultsThe mean DSC for the rectal spacer was 0.787 ± 0.073, with a mean HD₉₅ of 4.03 ± 1.83 mm and a mean MSD of 1.18 ± 0.63 mm. The adjacent organs showed high geometric agreement, with mean DSC values of 0.876, 0.890, and 0.963 for the prostate, rectum, and bladder, respectively. No systematic over- or under-segmentation was observed, and the MSD for all structures was below 2.5 mm.
conclusionsCT-based automatic segmentation using OncoStudio provided clinically acceptable boundary delineation of a non-radiopaque hydrogel rectal spacer without requiring MRI, while maintaining the contouring quality of the surrounding organ. These findings suggest that CT-only automatic contouring can reduce spacer-specific MRI use and associated registration uncertainty in prostate radiotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.